Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Joincare Pharmaceutical Group Industry Co Ltd (Joincare Pharma) is a pharmaceutical company that develops, manufactures and distributes pharmaceutical products. The company offers products such as active pharmaceutical ingredients, formulations, generics, and diagnostic reagents. It provides its products in various therapeutic areas including oncology, immunology, reproduction, cardiovascular, central nervous system, psychotropic, antivival, gastrointestinal, antibiotics and nutritional infusion, among others. The company offers its products in the forms of tablets, capsules, granules, and injections. Joincare Pharma is headquartered in Shenzhen, Guangdong, China.
Headquarters
China
Address
Building, No. 17 Langshan Road, North District, High-tech Zone, Shenzhen, Guangdong, 518057
Website
www.joincare.com
Telephone
86 755 86252368
No of Employees
14,000
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
600380 (SHA)
Revenue (2024)
$2.1B
-2.6%
(2024 vs 2023)
EPS
XYZ
Net Income (2024)
XYZ
-3.7%
(2024 vs 2023)
Market Cap*
$2.5B
Net Profit Margin (2024)
XYZ
-1.1%
(2024 vs 2023)
* As of and is in US$
Joincare Pharmaceutical Group Industry Co Ltd premium industry data and analytics
Products and Services
| Products |
|---|
| Active Pharmaceutical Ingredients (API) Products |
| Generic Products |
| Diagnostic Reagents |
| XYZ |
| XYZ |
| XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2024 | Contracts/Agreements | In January, the company entered into a partnership with Luye Pharma Group to develop and commercialize BA2101 in the Chinese Mainland to treat respiratory diseases such as asthma and COPD. |
| 2022 | Contracts/Agreements | In December, the company entered into a framework agreement with Livzon Pharma to establish a joint venture company by investing RMB10 million. |
| 2022 | Stock Listings/IPO | In June, the company announced its plans to list on the SIX Swiss stock exchange. |
Competitor Comparison
| Key Parameters | Joincare Pharmaceutical Group Industry Co Ltd | Huadong Medicine Co Ltd | Apeloa Pharmaceutical Co Ltd | Yabao Pharmaceutical Group Co Ltd | Beijing Tide Pharmaceutical Co Ltd |
|---|---|---|---|---|---|
| Headquarters | China | China | China | China | China |
| City | Shenzhen | Hangzhou | Jinhua | Beijing | Beijing |
| State/Province | Guangdong | Zhejiang | Zhejiang | Beijing | Beijing |
| No. of Employees | 14,000 | 19,095 | 6,787 | 3,415 | - |
| Entity Type | Public | Public | Public | Public | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer